Establishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I/II controlled trial

ANTONIO ROMERO RUIZ2026-01-292026-01-29202310.1016/j.ejso.2023.07.0042-s2.0-85166953249https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/36735OncologySurgeryEstablishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I/II controlled trialresearch article